Viscum album, or European mistletoe, has gained recognition as a supportive therapy in integrative oncology. Widely used in Europe for over a century, mistletoe extract is now being introduced in India through ABNOBA India, in collaboration with ABNOBA GmbH, a German pharmaceutical company known for its research-based and nature-focused approach.
The viscum album subcutaneous injection involves administering a carefully prepared extract of mistletoe just under the skin. This plant-based therapy is not a replacement for conventional cancer treatments but serves as a complementary therapy—aiming to improve quality of life, stimulate the immune system, and help the body cope with the side effects of chemotherapy and radiotherapy.
Studies show that viscum album may increase the activity of natural immune cells, promote tumor apoptosis (cell death), and improve overall well-being. Patients often report better energy, sleep, and appetite during mistletoe therapy.
What makes ABNOBA’s products stand out is their standardized production—using different host trees, seasonal harvesting, and advanced extraction processes to maintain high purity and potency. The result is ABNOBAvisc®, a range of viscum album injections trusted by oncologists and integrative medicine experts around the world.
As awareness of holistic and integrative cancer care grows, ABNOBA India is making these trusted therapies accessible to Indian patients and practitioners.
To learn more about viscum album therapy and how it can support cancer treatment journeys, visit www.abnoba.in
